Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”
1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8907060
Mutated Pseudomonas exotoxins with reduced antigenicity
granted -
US 8900599
Conjugates of Plasmodium falciparum surface proteins as malaria vaccines
granted -
US 8883448
Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes
granted -
US 8877914
Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes
granted -
US 8871206
Anti-human folate receptor beta antibodies and methods of use
granted -
US 8871789
Method of preventing or treating viral infection
granted -
US 8871902
Immunogenic POTE peptides and methods of use
granted -
US 8871906
Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes
granted -
US 8865672
Prevention of tissue ischemia and related methods
granted -
US 8859207
Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same
granted -
US 8859585
Scopolamine for the treatment of depression and anxiety
granted -
US 8858938
Human monoclonal antibodies against Hendra and Nipah viruses
granted -
US 8853277
Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)
granted -
US 8853160
GLP-1, exendin-4, peptide analogs and uses thereof
granted -
US 8846389
AAV4 vector and uses thereof
granted -
US 8841305
Activators of the human pyruvate kinase M2 receptor
granted -
US 8835613
β-mannosylceramide and stimulation of NKT cell anti-tumor immunity
granted -
US 8828936
Therapeutic use of SCGB3A2
granted -
US 8828380
Method for the treatment of pulmonary disease and method of producing proteins of use therein
granted -
US 8822196
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
granted -
US 8822540
Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation
granted -
US 8822434
Compositions and methods to treat cardiac diseases
granted -
US 8821866
Methods of treating and preventing colitis involving IL-13 and NK-T cells
granted -
US 8816059
Method for predicting and detecting tumor metastasis
granted